Masayon, Glydel A.
HRN: 22-01-02 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/22/2022
AMPICILLIN 250MG (VIAL)
09/22/2022
09/29/2022
IV
120mg
Q12
Potentially Septic Newborn (Thickly Msaf)
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes